MSD to create approximately 350 tasks with brand-new manufacturing facility on former north Dublin website

By  | 

A new manufacturing center, producing biologics-based medicines for the worldwide market, will be constructed on the firm’s previous website in Swords.

< figure rel =lightbox data-href= data-alt=MSD >< img alt =MSD title=MSD width=620 height= 350 src= > MSD That north Dublin site produced fertility and females’s health products however ceased operations in 2015,

with the loss of 570 jobs.It is understood that MSD originally looked for a purchaser for the website but have now decided to recycle it for this new purpose-built high tech facility.Planning for the new plant is presently underway -as is the recruitment drive -with the intention that it will be working by 2021. An MSD Ireland representative informed that”the choice to locate this brand-new facility in Ireland is a testament to the skill of MSD’s Irish employees and the high requirement of our existing operations”. “It enhances MSD’s commitment to Ireland and additional strengthens our global network,” stated the spokesperson.Managing Director of MSD Ireland Human being Health and head of

the MSD Ireland country leadership team Ger Brennan told RTE Radio 1that MSD are trying to find graduates and people in early phases of their career for the new roles. “Specialists, graduates from college, we’re likewise looking at quality, individuals in engineering and lab professionals,” he stated.

“There’s a variety of functions readily available so I believe that when they see the description of roles online today, people will be really thrilled to reach out”.

Mr Brennan said that although those who lost their tasks can use for the brand-new positions if they have “the ideal level of qualification and experience”, there is no assurance that they will be employed at the website.

“The manufacturing procedure we did at that time was very different. Today we are moving into the area of biologics, it’s a really different area of manufacturing”.

MSD’s Irish operations are central to the work it brings out worldwide, with over 50pc of its worldwide top 20 products now made here in Ireland.Director of BioPharmaChem Ireland Matt Moran said the statement demonstrates MSD’s “position at the heart of the corporation’s new products, and the cutting edge of biopharmaceutical development.”

“It is the mission of the market in Ireland to continue to support discovery and development in the production of life-changing medications, and to remain the worldwide area of choice for the advancement and manufacture of biopharmaceuticals. Ireland’s Life Sciences sector uses 60,000 individuals straight and indirectly, and in the last 10 years the market has actually invested 10 billion euro in brand-new centers in Ireland,” he said.

Ibec CEO Danny McCoy likewise welcomed of MCD’s expansion plans “as more evidence of the well-being of the biopharma market and favorable outlook for the sector in Ireland.”

Representatives MSD were at the launch of the Surefire Irish event, which occurred at the Irish Stock market last week.They shared their experiences of export markets, and how being Irish has actually added a competitive advantage to their business both in the house and abroad.MSD presently employs around 1800 individuals throughout its websites in Ireland, in the locations of manufacturing, R&D, commercial and marketing centers in addition to global support services.

Language »